Why it was recalled
Superpotent and Subpotent drugs
Product description
Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network
Lot numbers, UPCs & expiration codes
BUD: 10/04/2016, Lot number 04072016@40 BUD: 12/03/2016, Lot number 06162016@2 BUD: 01/07/2017, Lot number CA07112016@4
Where it was sold
U.S.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0126-2017
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Sep 19, 2016
- FDA report date
- Nov 16, 2016
- Quantity
- 690 pellets
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Wells Pharmacy Network, LLC
Original FDA data
Every field from FDA enforcement report D-0126-2017, exactly as published.
Show all FDA fields
- City
- Dyersburg
- State
- TN
- Status
- Terminated
- Country
- United States
- Event ID
- 75247
- Address
- 450 US Hwy 51 Byp N
- Code information
- BUD: 10/04/2016, Lot number 04072016@40 BUD: 12/03/2016, Lot number 06162016@2 BUD: 01/07/2017, Lot number CA07112016@4
- Postal code
- 38024-3655
- Report date
- Nov 16, 2016
- Product type
- Drugs
- Recall number
- D-0126-2017
- Classification
- Class II
- Recalling firm
- Wells Pharmacy Network, LLC
- Product quantity
- 690 pellets
- Termination date
- Mar 29, 2017
- Reason for recall
- Superpotent and Subpotent drugs
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network
- Distribution pattern
- U.S.
- Recall initiation date
- Sep 19, 2016
- Initial firm notification
- Telephone
- Center classification date
- Nov 8, 2016